Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Viral Diversity an Innovative Biomarker for Refining Estimates of HIV Incidence

Award Number: K43TW012350
ORGANIZATION: FOGARTY INTERNATIONAL CENTER
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/01/2022
PERIOD OF PERFORMANCE END DATE: 06/30/2027

Group Awards By:

View Award Description

Viral Diversity an Innovative Biomarker for Refining Estimates of HIV Incidence - Project Summary Candidate: Dr Sikhulile Moyo is unwaveringly committed to an overarching career focused on contributing to ending the HIV epidemic and related public health emergencies. He committed to a career focused on finding cost-effective tools for estimating the impact of interventions and towards HIV cure research. He envisions himself as a leader globally, in research aimed towards tracking and eliminating new HIV infections & towards developing an HIV cure, working with researchers, program implementers and policy makers for rapid and cost-effective evaluation of interventions. Dr Moyo’s 5-year career development plan is focused on three key areas: phylogenetics, epidemiology and biostatistics; cross-sectional Incidence and Implementation; and HIV cure & characterization of early founder viruses, and SARS-COV-2 genomics. In order to achieve his short- and medium-term career objectives he seeks to: a) develop advanced methodologic and analytic skills in molecular epidemiology, phylogenetic analysis and bioinformatics; b) expand laboratory expertise in real-time high-throughput next generation sequencing and accurate and reliable quantification of proviral reservoirs for advancing HIV cure studies, and c) strengthen leadership abilities particularly in managing large scientific projects, population-level surveys, and diverse research teams with expertise in different fields, organizational leadership and student research supervision. Training activities will encompass formal training and coursework, practical application through the proposed research project, and direct mentorship from my highly experienced mentorship and advisory team. These activities will draw on the strengths of the mentorship team and leading research institutions with strong collaborative ties and have a record of mentoring young investigators to R01 and independence. Research: The study aims to introduce an innovative approach to estimating HIV incidence, which is very important for national HIV programs / public health, and also for HIV prevention research, but can be expensive and challenging to do. The specific aims are: 1) To assess adjusted viral diversity as a potential biomarker of HIV incidence. 2) To refine results of serological screening in subsets of true- and false-recent cases, and patients with established infection (ART-naïve and on ART), by adjusted viral diversity. We will test whether viral diversity within the most informative regions across the HIV-1C genome adjusted for multiplicity of transmission, recombination, and level of viral replication could be used to refine the results of serological screening and improve specificity and sensitivity. We expect that the adjusted viral diversity within the most informative regions will increase specificity and sensitivity in estimation of HIV incidence within the 4 subsets of individuals targeted in this Aim to ≥95%. Establishing a cost-effective algorithm to estimate incidence is of critical public health importance in low resource settings.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $136,468 )
2025	2025	THE BOTSWANA HARVARD HEALTH PARTNERSHIP	PRINCESS MARINA HOSPITAL PLOT 1836 NORTH RING R	BOTSWANA				BWA	International Research and Research Training	000	4	7/14/2025	NON-COMPETING CONTINUATION	$136,468
														Subtotal = $136,468

Issue Date FY: 2024 ( Subtotal = $136,460 )
2024	2024	BOTSWANA HARVARD AIDS INSTITUTE	PRINCESS MARINA HOSPITAL PLOT 1836 NORTH RING R	BOTSWANA				BWA	International Research and Research Training	000	3	6/20/2024	NON-COMPETING CONTINUATION	$136,460
														Subtotal = $136,460

Issue Date FY: 2023 ( Subtotal = $136,537 )
2023	2023	BOTSWANA HARVARD AIDS INSTITUTE	PRINCESS MARINA HOSPITAL PLOT 1836 NORTH RING R	BOTSWANA				BWA	International Research and Research Training	000	2	6/19/2023	NON-COMPETING CONTINUATION	$136,537
														Subtotal = $136,537

Issue Date FY: 2022 ( Subtotal = $136,526 )
2022	2022	BOTSWANA HARVARD AIDS INSTITUTE	PRINCESS MARINA HOSPITAL PLOT 1836 NORTH RING R	BOTSWANA	NULL			BWA	International Research and Research Training	000	1	8/3/2022	NEW	$136,526
														Subtotal = $136,526

Grand Total All Awards = $545,991

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Viral Diversity an Innovative Biomarker for Refining Estimates of HIV Incidence

Award Number: K43TW012350

ORGANIZATION: FOGARTY INTERNATIONAL CENTER

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/01/2022

PERIOD OF PERFORMANCE END DATE: 06/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer